Some treatment planning considerations for 103Pd and 125I permanent interstitial implants
- 31 December 1992
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (5), 1131-1138
- https://doi.org/10.1016/0360-3016(92)90820-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Clinical implementation of AAPM Task Group 32 recommendations on brachytherapy source strength specificationMedical Physics, 1991
- Dosimetry on transverse axes of 125I and 192Ir interstitial brachytherapy sourcesMedical Physics, 1990
- Dose rate determination for 125I seedsMedical Physics, 1990
- Dose parameters of 125I and 192Ir seed sourcesMedical Physics, 1989
- The accuracy of single-seed dose superposition for I-125 implantsMedical Physics, 1989
- Studies with encapsulated 125I sources. II. determination of the relative biological effectiveness using cultured mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Dose inhomogeneity in interstitial implants using 125I seedsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Time-dose factor (TDF) analysis of dose rate effects in permanent implant dosimetryInternational Journal of Radiation Oncology*Biology*Physics, 1977